What You Should Know:
- Duke Health, a renowned healthcare system, and SAS, a global leader in data and AI, have formalized a two-year collaboration to leverage cutting-edge technology to transform healthcare operations and patient care.
- Following successful partnerships with industry leaders such as Microsoft and nference, Duke Health's collaboration with SAS aims to create innovative AI-powered tools. These tools will enhance healthcare delivery processes, ultimately improving
Read More
CGMs Through Medical Benefits: Improved Adherence and Cost Savings for Diabetes Patients, New Research Shows
What You Should Know:
- A research study by CCS, a leading chronic care management company, reveals that patients receiving continuous glucose monitoring (CGM) devices through medical benefits experience superior adherence and lower costs compared to those accessing them through pharmacy benefits.
- The JMIR Diabetes research — Exploring Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients with Diabetes: Impact of Device Sourcing, highlights
Read More
Dandelion Health Launches Clinical AI Marketplace + GLP-1 Study
What You Should Know:
- Dandelion Health, a real-world data (RWD) and clinical AI platform, today announced findings from a study that suggests GLP-1 medications may be effective in preventing cardiovascular disease (CVD) in a significantly larger population than previously thought.
- This research, conducted using validated AI on Dandelion's newly launched Clinical AI Marketplace, opens the door for a new era of precision medicine and personalized care in cardiometabolic
Read More
FDA Clears Eversense® 365: The World’s First One-Year CGM System
What You Should Know:
- Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system.
- This marks a significant advancement in diabetes management, offering a fully-implantable, long-term continuous glucose monitoring (CGM) solution for individuals with Type 1 and Type 2 diabetes aged 18 and older.
Eversense 365: Uninterrupted Living with Diabetes
Eversense 365 is set to transform the lives of people with diabetes by
Read More
Oracle Health Enhances Veteran Care with Free Interoperability Code
What You Should Know:
- Oracle Health today announced the release of new free code designed to enable its customers to support the Veteran Interoperability Pledge.
- This framework facilitates the secure sharing of patient health information between the U.S. Department of Veterans Affairs (VA) and community providers, enhancing the care of Veterans receiving treatment both within and outside the VA network.
Seamless Integration and Access
The new code enables Oracle
Read More
Jack Nathan Health® Explores Strategic Alternatives
What You Should Know:
- Jack Nathan Medical Corp. (TSXV: JNH; OTCQB: JNHMF), operating as Jack Nathan Health®, a leading Canadian healthcare network has entered into a non-binding letter of intent (LOI) for a proposed transaction. This development follows the company’s recent announcements regarding the exploration of strategic alternatives.
- A 30-day exclusivity period has been agreed upon with the other party involved in the LOI. Jack Nathan Medical Corp. has also secured
Read More
GI Partners Makes Major Investment in eClinical Solutions
What You Should Know:
- eClinical Solutions LLC, a provider of digital clinical software and services, announced that it has received a majority investment from GI Partners, a private investment firm.
- This investment highlights eClinical Solutions' strong position as a trusted partner for life science organizations of all sizes seeking to accelerate research and advance therapeutic breakthroughs in an increasingly complex trial landscape.
GI Partners' Commitment to
Read More
Noom Launches $149 GLP-1 Weight Loss Program with Sustainable Approach
What You Should Know:
- Noom, a digital healthcare company, is shaking up the weight loss industry with the launch of Noom GLP-1Rx, an innovative program offers affordable, accessible, and sustainable weight loss by combining compounded GLP-1 injections with Noom's proven behavioral change program.
- Noom GLP-1Rx delivers highly efficacious medications to the door within seven days starting at $149 and pairs those powerful medications with Noom GLP-1 Companion with Muscle
Read More
Stakeholders Urge Congress and White House to Maintain Remote Prescribing Flexibilities
What You Should Know:
- Over 330 stakeholder organizations have joined forces to call on Congress and the White House to intervene and ensure ongoing access to remote prescribing of controlled substances.
- Led by the American Telemedicine Association (ATA) and ATA Action, these organizations are concerned about the potential for the Drug Enforcement Administration (DEA) to significantly limit virtual prescribing, either through new regulations or by allowing existing
Read More
Study Reveals AI Predicts Patient Risk in Polypharmacy Seniors
What You Should Know:
- A new study published in The American Journal of Managed Care (AJMC) highlights the potential of AI-powered technology to address the complex issue of polypharmacy in senior patients.
- The study, conducted by researchers at Brigham and Women’s Hospital, evaluated FeelBetter’s platform and found it to be highly effective in predicting medication risks and stratifying patients based on their likelihood of hospitalization or emergency department visits.
The
Read More
